Article Versions Notes

Loosen SH, Ulmer TF, Labuhn S, Bednarsch J, Lang SA, Alizai PH, Schneider AT, Vucur M, Neumann UP, Luedde T, et al. Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer. Cancers. 2022; 14(17):4073. https://doi.org/10.3390/cancers14174073

Loosen, Sven H., Tom F. Ulmer, Simon Labuhn, Jan Bednarsch, Sven A. Lang, Patrick H. Alizai, Anne T. Schneider, Mihael Vucur, Ulf P. Neumann, Tom Luedde, and et al. 2022. "Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer" Cancers 14, no. 17: 4073. https://doi.org/10.3390/cancers14174073

Loosen, S. H., Ulmer, T. F., Labuhn, S., Bednarsch, J., Lang, S. A., Alizai, P. H., Schneider, A. T., Vucur, M., Neumann, U. P., Luedde, T., & Roderburg, C. (2022). Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer. Cancers, 14(17), 4073. https://doi.org/10.3390/cancers14174073